Abstract
Ductal carcinoma in situ (DCIS) of the breast is a pre-invasive breast malignancy with controversial clinical relevance and management. These lesions have increased in incidence with breast cancer screening programs and are associated with increasingly recognized clinical issues of overdiagnosis and overtreatment. This article discusses the imaging presentation of these lesions with emphasis on advances in breast MRI and its role in the management of DCIS.